These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27283886)

  • 1. Dexamethasone - PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation.
    Yavuz B; Bozdağ Pehlivan S; Sümer Bolu B; Nomak Sanyal R; Vural İ; Ünlü N
    J Pharm Pharmacol; 2016 Aug; 68(8):1010-20. PubMed ID: 27283886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro/In Vivo Evaluation of Dexamethasone--PAMAM Dendrimer Complexes for Retinal Drug Delivery.
    Yavuz B; Pehlivan SB; Vural İ; Ünlü N
    J Pharm Sci; 2015 Nov; 104(11):3814-3823. PubMed ID: 26227825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
    Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
    J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
    Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
    Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative anti-inflammatory activity of poly(amidoamine) (PAMAM) dendrimer-dexamethasone conjugates with dexamethasone-liposomes.
    Choksi A; Sarojini KV; Vadnal P; Dias C; Suresh PK; Khandare J
    Int J Pharm; 2013 Jun; 449(1-2):28-36. PubMed ID: 23583708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.
    Hou H; Wang C; Nan K; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):557-66. PubMed ID: 26882530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation.
    Soiberman U; Kambhampati SP; Wu T; Mishra MK; Oh Y; Sharma R; Wang J; Al Towerki AE; Yiu S; Stark WJ; Kannan RM
    Biomaterials; 2017 May; 125():38-53. PubMed ID: 28226245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Poly(amidoamine) Dendrimers Safe for Ocular Applications? Toxicological Evaluation in Ocular Cells and Tissues.
    Qin C; Wen S; Zhu S; Liu D; Chen S; Qie J; Chen H; Lin Q
    J Ocul Pharmacol Ther; 2020 Dec; 36(10):715-724. PubMed ID: 33121321
    [No Abstract]   [Full Text] [Related]  

  • 9. In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.
    Najlah M; Freeman S; Khoder M; Attwood D; D'Emanuele A
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28976921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched Polymer-Drug Conjugates for Multivalent Blockade of Angiotensin II Receptors.
    Hennig R; Veser A; Kirchhof S; Goepferich A
    Mol Pharm; 2015 Sep; 12(9):3292-302. PubMed ID: 26252154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylated Dendrimer Mediated Delivery of Bortezomib: Drug Conjugation versus Encapsulation.
    Sahoo RK; Gothwal A; Rani S; Nakhate KT; Ajazuddin ; Gupta U
    Int J Pharm; 2020 Jun; 584():119389. PubMed ID: 32380027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosted Memory and Improved Brain Bioavailability of Rivastigmine: Targeting Effort to the Brain Using Covalently Tethered Lower Generation PAMAM Dendrimers with Lactoferrin.
    Gothwal A; Nakhate KT; Alexander A; Ajazuddin ; Gupta U
    Mol Pharm; 2018 Oct; 15(10):4538-4549. PubMed ID: 30156844
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Nazlı H; Gedik G
    Pharm Dev Technol; 2021 Sep; 26(7):750-764. PubMed ID: 34154500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-atomistic molecular dynamics (AA-MD) studies and pharmacokinetic performance of PAMAM-dendrimer-furosemide delivery systems.
    Otto DP; de Villiers MM
    Int J Pharm; 2018 Aug; 547(1-2):545-555. PubMed ID: 29908331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendrimers for Drug Delivery.
    Chauhan AS
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29670005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic studies of poly(amidoamine) dendrimer based simvastatin oral formulations for the treatment of hypercholesterolemia.
    Kulhari H; Kulhari DP; Prajapati SK; Chauhan AS
    Mol Pharm; 2013 Jul; 10(7):2528-33. PubMed ID: 23692066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of poly(amidoamine) dendrimers on ocular absorption of puerarin using microdialysis.
    Yao C; Wang W; Zhou X; Qu T; Mu H; Liang R; Wang A; Sun K
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):565-9. PubMed ID: 21895496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene--in vivo study.
    Borowska K; Wołowiec S; Rubaj A; Głowniak K; Sieniawska E; Radej S
    Int J Pharm; 2012 Apr; 426(1-2):280-283. PubMed ID: 22310461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery.
    Zhang Z; Yu J; Zhou Y; Zhang R; Song Q; Lei L; Li X
    Colloids Surf B Biointerfaces; 2018 Apr; 164():436-443. PubMed ID: 29438842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation.
    Prieto E; Cardiel MJ; Vispe E; Idoipe M; Garcia-Martin E; Fraile JM; Polo V; Mayoral JA; Pablo LE; Rodrigo MJ
    Biomed Mater; 2020 Nov; 15(6):065021. PubMed ID: 32647098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.